Seventeen-year clinical outcome of schizophrenia in Bali

T. Kurihara, M. Kato, R. Reverger, I. G R Tirta

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objective: To examine the 17-year clinical outcome of schizophrenia and its predictors in Bali. Methods: Subjects were 59 consecutively admitted first-episode schizophrenia patients. Their clinical outcome was evaluated by standardized symptomatic remission criteria based on Positive and Negative Syndrome Scale (PANSS) scores and operational functional remission criteria at 17-year follow-up. The standardized mortality ratio (SMR) over 17 years was also calculated as another index of clinical outcome. Results: Among these 59 patients, 43 (72.9%) could be followed-up, 15 (25.4%) had died, and one (1.7%) was alive but refused to participate in the study. Combined remission (i.e. symptomatic and functional remission) was achieved in 14 patients (23.7% of original sample). Duration of untreated psychosis (DUP) was a significant baseline predictor of combined remission. Mean age at death of deceased subjects was 35.7, and SMR was 4.85 (95% CI: 2.4-7.3), indicating that deaths were premature. Longer DUP was associated with excess mortality. Conclusions: The long-term outcome of schizophrenia in Bali was heterogeneous, demonstrating that a quarter achieved combined remission, half were in nonremission, and a quarter had died at 17-year follow-up. DUP was a significant predictor both for combined remission and mortality.

Original languageEnglish
Pages (from-to)333-338
Number of pages6
JournalEuropean Psychiatry
Volume26
Issue number5
DOIs
Publication statusPublished - 2011 Jul

Fingerprint

Schizophrenia
Psychotic Disorders
Mortality
Premature Mortality

Keywords

  • Developing countries
  • First-episode psychosis
  • Outcome assessment

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Kurihara, T., Kato, M., Reverger, R., & Tirta, I. G. R. (2011). Seventeen-year clinical outcome of schizophrenia in Bali. European Psychiatry, 26(5), 333-338. https://doi.org/10.1016/j.eurpsy.2011.04.003

Seventeen-year clinical outcome of schizophrenia in Bali. / Kurihara, T.; Kato, M.; Reverger, R.; Tirta, I. G R.

In: European Psychiatry, Vol. 26, No. 5, 07.2011, p. 333-338.

Research output: Contribution to journalArticle

Kurihara, T, Kato, M, Reverger, R & Tirta, IGR 2011, 'Seventeen-year clinical outcome of schizophrenia in Bali', European Psychiatry, vol. 26, no. 5, pp. 333-338. https://doi.org/10.1016/j.eurpsy.2011.04.003
Kurihara, T. ; Kato, M. ; Reverger, R. ; Tirta, I. G R. / Seventeen-year clinical outcome of schizophrenia in Bali. In: European Psychiatry. 2011 ; Vol. 26, No. 5. pp. 333-338.
@article{a3d253d0a223456199e43c34e0b68108,
title = "Seventeen-year clinical outcome of schizophrenia in Bali",
abstract = "Objective: To examine the 17-year clinical outcome of schizophrenia and its predictors in Bali. Methods: Subjects were 59 consecutively admitted first-episode schizophrenia patients. Their clinical outcome was evaluated by standardized symptomatic remission criteria based on Positive and Negative Syndrome Scale (PANSS) scores and operational functional remission criteria at 17-year follow-up. The standardized mortality ratio (SMR) over 17 years was also calculated as another index of clinical outcome. Results: Among these 59 patients, 43 (72.9{\%}) could be followed-up, 15 (25.4{\%}) had died, and one (1.7{\%}) was alive but refused to participate in the study. Combined remission (i.e. symptomatic and functional remission) was achieved in 14 patients (23.7{\%} of original sample). Duration of untreated psychosis (DUP) was a significant baseline predictor of combined remission. Mean age at death of deceased subjects was 35.7, and SMR was 4.85 (95{\%} CI: 2.4-7.3), indicating that deaths were premature. Longer DUP was associated with excess mortality. Conclusions: The long-term outcome of schizophrenia in Bali was heterogeneous, demonstrating that a quarter achieved combined remission, half were in nonremission, and a quarter had died at 17-year follow-up. DUP was a significant predictor both for combined remission and mortality.",
keywords = "Developing countries, First-episode psychosis, Outcome assessment",
author = "T. Kurihara and M. Kato and R. Reverger and Tirta, {I. G R}",
year = "2011",
month = "7",
doi = "10.1016/j.eurpsy.2011.04.003",
language = "English",
volume = "26",
pages = "333--338",
journal = "European Psychiatry",
issn = "0924-9338",
publisher = "Elsevier Masson",
number = "5",

}

TY - JOUR

T1 - Seventeen-year clinical outcome of schizophrenia in Bali

AU - Kurihara, T.

AU - Kato, M.

AU - Reverger, R.

AU - Tirta, I. G R

PY - 2011/7

Y1 - 2011/7

N2 - Objective: To examine the 17-year clinical outcome of schizophrenia and its predictors in Bali. Methods: Subjects were 59 consecutively admitted first-episode schizophrenia patients. Their clinical outcome was evaluated by standardized symptomatic remission criteria based on Positive and Negative Syndrome Scale (PANSS) scores and operational functional remission criteria at 17-year follow-up. The standardized mortality ratio (SMR) over 17 years was also calculated as another index of clinical outcome. Results: Among these 59 patients, 43 (72.9%) could be followed-up, 15 (25.4%) had died, and one (1.7%) was alive but refused to participate in the study. Combined remission (i.e. symptomatic and functional remission) was achieved in 14 patients (23.7% of original sample). Duration of untreated psychosis (DUP) was a significant baseline predictor of combined remission. Mean age at death of deceased subjects was 35.7, and SMR was 4.85 (95% CI: 2.4-7.3), indicating that deaths were premature. Longer DUP was associated with excess mortality. Conclusions: The long-term outcome of schizophrenia in Bali was heterogeneous, demonstrating that a quarter achieved combined remission, half were in nonremission, and a quarter had died at 17-year follow-up. DUP was a significant predictor both for combined remission and mortality.

AB - Objective: To examine the 17-year clinical outcome of schizophrenia and its predictors in Bali. Methods: Subjects were 59 consecutively admitted first-episode schizophrenia patients. Their clinical outcome was evaluated by standardized symptomatic remission criteria based on Positive and Negative Syndrome Scale (PANSS) scores and operational functional remission criteria at 17-year follow-up. The standardized mortality ratio (SMR) over 17 years was also calculated as another index of clinical outcome. Results: Among these 59 patients, 43 (72.9%) could be followed-up, 15 (25.4%) had died, and one (1.7%) was alive but refused to participate in the study. Combined remission (i.e. symptomatic and functional remission) was achieved in 14 patients (23.7% of original sample). Duration of untreated psychosis (DUP) was a significant baseline predictor of combined remission. Mean age at death of deceased subjects was 35.7, and SMR was 4.85 (95% CI: 2.4-7.3), indicating that deaths were premature. Longer DUP was associated with excess mortality. Conclusions: The long-term outcome of schizophrenia in Bali was heterogeneous, demonstrating that a quarter achieved combined remission, half were in nonremission, and a quarter had died at 17-year follow-up. DUP was a significant predictor both for combined remission and mortality.

KW - Developing countries

KW - First-episode psychosis

KW - Outcome assessment

UR - http://www.scopus.com/inward/record.url?scp=79960442061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960442061&partnerID=8YFLogxK

U2 - 10.1016/j.eurpsy.2011.04.003

DO - 10.1016/j.eurpsy.2011.04.003

M3 - Article

VL - 26

SP - 333

EP - 338

JO - European Psychiatry

JF - European Psychiatry

SN - 0924-9338

IS - 5

ER -